News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article identifies three penny stocks—Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN)—that exhibit strong financial health despite their low share prices, making them attractive to retail investors. The analysis, derived from Simply Wall St's "Financially Fit Penny Stocks" screener, highlights each company's operations, …
Enovix Corporation's average 12-month price target has been adjusted to $13.5 from $13.72 by 9 analysts, with a range between $5.5 and $25 per share. This new target suggests a potential upside of approximately 185% based on the recent closing price. The consensus rating …
Cantor Fitzgerald has reiterated an Overweight rating and a $25.00 price target for Enovix Corporation (NASDAQ:ENVX) following strong Q2 2026 financial results, which exceeded analyst estimates. The battery technology company demonstrated significant progress in its smartphone cell qualification, smart eyewear shipments, and drone/defense pipeline …
Cantor Fitzgerald has reissued an "overweight" rating for Enovix (NASDAQ:ENVX) with a $25 price target, suggesting a significant upside. Despite beating Q2 revenue and EPS estimates, the company remains unprofitable and faces investor skepticism due to its negative net margin and expectations of another …
Enovix Corp (ENVX) reported a 21% year-over-year revenue increase to $9 million in Q2 2026, marking its fifth consecutive quarter of growth, driven by a significant ramp-up in smart eyewear battery shipments and a surge in its drone and defense pipeline to $180 million. …
Earnings Call Insights: Enovix Corporation (ENVX) Q2 2026 MANAGEMENT VIEW * “The second quarter showed momentum across all 3 of our primary target markets,” and in smartphones “our lead customer confirmed that our cells passed more than 1,000 cycles on the 0.2C discharge cycle …
Enovix Corporation (ENVX) stock closed at $4.73, retreating from an intraday high, with its daily chart remaining in a downtrend despite some short-term bounce signals. While daily momentum indicators suggest a pause, not a reversal, hourly charts indicate that the bounce is losing conviction …
Enovix (ENVX) reported a smaller-than-expected Q2 2026 loss and higher revenue, yet its shares declined after hours due to investor concerns over near-term margin pressure. The company highlighted progress in smartphone qualification, smart eyewear production, and a growing defense pipeline. Despite beating estimates, the …
Enovix Corporation (ENVX) reported a Q2 loss of $0.13 per share, exceeding the Zacks Consensus Estimate of a $0.14 loss, and surpassed revenue estimates with $9.02 million. Despite consistently beating EPS estimates over the last four quarters, the company's shares have declined 33.9% year-to-date. …
Enovix Corporation reported Q2 revenue of $9 million, surpassing FactSet's estimate of $8.4 million. The company also released its Q3 outlook, expecting a non-GAAP net loss per share between $0.17 and $0.13 and revenue ranging from $9 million to $10 million. Enovix specializes in …
Enovix Corporation reported increased revenue for both the fiscal quarter and year-to-date periods ending July 5, 2026, primarily driven by sales to defense and industrial customers. Despite revenue growth, the company experienced wider net losses for the year-to-date, reaching $81.3 million, largely due to …
Enovix Corp (ENVX) reported its second-quarter 2026 results, showing a revenue increase to $9.02M, up 20.8% year-over-year. Despite the revenue growth, the company posted a net loss of ($43.06M) and a diluted loss per share of ($0.2). Business highlights include the launch of the …
This article identifies three "financially fit" penny stocks—Enovix (ENVX), Clover Health Investments (CLOV), and Hyliion Holdings (HYLN)—that exhibit stronger balance sheets and financial health compared to many early-stage peers. Enovix focuses on advanced lithium-ion batteries, Clover Health offers Medicare Advantage plans and healthcare software, …
Enovix Corp's President and CEO, Rajendra K. Talluri, reported a Form 4 transaction where 4,300 shares of common stock were withheld to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). This transaction, valued at $4.70 per share, was a tax-related …
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported the withholding of 936 common shares valued at $4.70 per share to cover tax obligations from vested restricted stock units (RSUs). Following this transaction, Chakravarthy directly retains 583,535 shares of Enovix common stock. This total includes …
Enovix Corp's Chief Operating Officer, Michael Vyvoda, was granted 932,400 Restricted Stock Units (RSUs) which will vest over time, with 25% vesting on August 5, 2026, and the remainder in quarterly installments, contingent on his continued employment. Additionally, he received 23,310 fully vested shares …
Enovix Corp (ENVX) has filed an initial Form 3, reporting that Michael Vyvoda, the Chief Operating Officer, is now a reporting person. The filing itself does not indicate any transactions or derivative positions but does note the attachment of a Power of Attorney as …
This article identifies three "financially fit" penny stocks: Enovix (ENVX), Grab Holdings (GRAB), and Clover Health Investments (CLOV). It highlights their respective market opportunities—advanced battery technology, Southeast Asian super app, and tech-driven Medicare Advantage plans—while also noting associated risks and financial metrics. The article …
First Trust Advisors LP has reduced its stake in Enovix Corporation (NASDAQ:ENVX) by 42.4% in the first quarter, selling 351,606 shares and retaining 476,903 shares valued at approximately $2.47 million. The company reported a quarterly loss of $0.14 per share, beating estimates, with revenue …
This article highlights three financially strong penny stocks identified by Simply Wall St's screener: Enovix (ENVX), Clover Health Investments (CLOV), and Hyliion Holdings (HYLN). Enovix is an innovative battery company with strong growth forecasts despite current losses, while Clover Health Investments, a Medicare Advantage …
Faruqi & Faruqi, LLP is investigating potential claims against Enovix Corp. and reminds investors of a March 7, 2023 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges that Enovix overstated its ability to produce batteries …
This article identifies three AI infrastructure penny stocks—Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN)—that are highlighted by Simply Wall St's "Financially Fit Penny Stocks" screener. These companies are presented as having stronger balance sheets despite their low share prices and potential for growth …
This article highlights three financially strong penny stocks identified by Simply Wall St's screener: Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN). Enovix focuses on next-generation battery technology, Snap operates the Snapchat app with a focus on AR and subscriptions, and Hyliion Holdings develops …
This article identifies three "financially fit" penny stocks—Enovix (ENVX), Snap (SNAP), and Hyliion Holdings (HYLN)—that are positioned to benefit from advancements in AI and increased device demand. It highlights their current operations, market capitalization, and potential, while also noting existing risks and challenges, suggesting …
MarketBeat.com reports that Enovix Corporation (NASDAQ:ENVX) has received a consensus "Hold" recommendation from ten ratings firms. While two analysts suggest selling and six recommend buying, the average 12-month price target is $12.50. The article also details recent analyst price target adjustments and institutional investor …
Enovix (NASDAQ:ENVX) recently hit a new 52-week low, with shares trading as low as $3.85 after closing at $3.97, significantly below its moving averages. Despite reporting better-than-expected revenue and EPS, the company remains highly unprofitable. Analyst sentiment is mixed but leaning towards caution, with …
Enovix Corp (ENVX) is trading at $3.98, down 5.91%, with a market cap of $866.44 million. Analysts currently rate the stock as a "Buy" with a target price of $22.35, suggesting a significant upside. Despite strong fundamentals and growth potential, the stock has shown …
This article from Investing.com reports on a Form 4 filing for Enovix Corp (ENVX) relevant to July 28th. The brief notice indicates a financial disclosure made by the company, with no further details provided in the body of the article.
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, had 2,221 shares withheld on July 24, 2026, at $3.95 per share to cover tax obligations from vesting Restricted Stock Units (RSUs). After this transaction, Chakravarthy directly holds 584,471 shares, which includes RSUs and Performance Restricted Stock …
Search by ticker symbol or company name and select a result to open its chart.